Dr. SATYABRATA BARIK

Experience

• 

  Troikaa Pharmaceuticals Ltd.

  Jun 2007 - Sept 2009

  Executive (Formulation Development at Troikaa Pharma Ltd.)

  I was working as an Executive in Formulation Development Dept. for NDDS products for solid oral dosage form and liquid injectables and soft gelatin capsule.

• 

  Zydus Group

  Sept 2009 - Apr 2011

  Sr.Research Associate (Formulation Development at Zydus-Cadila Ltd.

  I was working as Research Associate in Formulation Development Dept.for Solid Oral Dosage form for Regulatory Market.

• 

  Ajanta Pharma Ltd

  Apr 2011 - Oct 2012

  Sr.Executive (Formulation Development Ajanta pharmaceuticals Ltd.)

  Formulation and Development for Solid Oral Dosage form like ER tablets, Softgel capsules ,CR Tablets( OROS Technology), for Europe & US(ANDA)Market (Para-III and Para-IV Projects)

• 

  AUROBINDO PHARMA LTD

  Nov 2012 - Nov 2021

  Working on Solid Oral Dosage form for Regulatory Markets (USA- ANDA ,EU and ROW)Expertise on DR oral suspension, Liquid oral suspension.Formulation development strategies for NCE-1 and Para IV approaches.Risk Assessment of the formulation and process to anticipate and control the risk parameters so as to build quality in to the product right at the stage of development and technology transfer. • Expertise on Solid Oral Dosage form for Regulatory Markets (USA- ANDA & EU) To actively supervising and managing a team for performing product development activities of solid oral dosage forms.Formulation development activities and processes for solid dosage forms.(US, Europe, ROW)Design of Experimentation and Quality by Design (QbD) aspects for formulation development Formulation Development of solid orals for US and Europe market.Plans work independently based on specific objectives.Scale-up and technology transfer experience to pilot/commercial scale.

  • Sr. Manager Formulation Development

    Jan 2018 - Nov 2021

  • Manager

    Oct 2016 - Jan 2018

  • Deputy Manager (Formulation Development Aurobindo Research center).

    Oct 2014 - Oct 2016

  • Asst. Manager (Formulation Development Aurobindo Research center).

    Nov 2012 - Oct 2014
• 

  Sekhmet Pharmaventures

  Nov 2021 - Feb 2024

  Associate Director Formulation and Development ( A Sekhmet Pharma Venture company)

  To lead multiple projects as per the department needs.Solid Oral Dosage form for Regulatory Markets (USA- ANDA & EU).Expertise on design of experiments (DOE) by design expert software independently and carryout scientific work with the knowledge of the technology.Handling of NCE-1, MUPS technology, Palletization technology, in- Vitro in-Vivo correlation Complex generic molecules, genotoxicity & Nitrosamine risk Evaluation,

• 

  Hetero

  Feb 2024 - now

  Assistant General Manager Formulation R&D